Solid Biosciences Inc.
SLDB· Nasdaq
Released Aug 10, 2018, before the open
10-Q filed Aug 10, 2018, 41 days after period end · 0001193125-18-245070
| Metric | Q2 2018 | Q2 2017 |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| Net Income | -$17.98M | -$11.31M |
| EPS Diluted | -$0.52 | -$0.66 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Solid Biosciences Inc. · CIK 1707502 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Jun 30, 2018 · filed Aug 10, 2018 · 41 d after period end
2.1% from the close of Aug 9, 2018 to the close of Aug 10, 2018, the first after the release.